Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes-Reference-Cited by-同舟云学术

Modeling polymorphic ventricular tachycardia at rest using patient-specific induced pluripotent stem cell-derived cardiomyocytes

Published:2020-10 Issue: Volume:60 Page:103024
ISSN:2352-3964
Container-title:EBioMedicine
language:en
Short-container-title:EBioMedicine

Author:

Sleiman Yvonne,Souidi Monia,Kumar Ritu,Yang Ellen,Jaffré Fabrice^ORCID,Zhou Ting,Bernardin Albin,Reiken Steve,Cazorla Olivier,Kajava Andrey V.,Moreau Adrien,Pasquié Jean-Luc,Marks Andrew R.,Lerman Bruce B.,Chen Shuibing,Cheung Jim W.,Evans Todd,Lacampagne Alain,Meli Albano C.^ORCID

Funder

Fondation pour la Recherche Médicale

Foundation for the National Institutes of Health

French Muscular Dystrophy Association

New York State Department of Health

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference38 articles.

1. A novel ryanodine receptor mutation linked to sudden death increases sensitivity to cytosolic calcium;Meli;Circ Res,2011

2. Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia;Priori;Circulation,2001